Significantly more patients in the high-Hb group reported histories of hypertension (95.8% vs 93.2%; P = 0.03) or coronary artery bypass grafts (17.4% vs 13.5%; P = 0.05) at baseline, suggesting an uneven baseline cardiovascular risk burden between the groups. Here, GSTM1 is linked to Hypertension.